In the article titled "A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation" \[[@B1]\], the number of probiotics in the formulation mixtures in subsection "2.1. Study Design" in Materials and Methods was written incorrectly as follows:

"The composition of the probiotic mix F_1 was as follows: 5 × 10^9^ CFU*L. acidophilus* (30 mg as lyophilized), 5 × 10^9^ CFU*L. reuteri* (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 5 × 10^9^ CFU*L. plantarum* (12 mg as lyophilized), 5 × 10^9^ CFU*L. rhamnosus* (20 mg as lyophilized), 5 × 10^9^ CFU*B. animalis* subsp.*lactis* (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, 5 mg talc."

It should be corrected to the following: "The composition of the probiotic mix F_1 was as follows: 2 × 10^9^ CFU*L. acidophilus* (30 mg as lyophilized), 2 × 10^9^ CFU*L. reuteri* (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 2 × 10^9^ CFU*L. plantarum* (12 mg as lyophilized), 2 × 10^9^ CFU*L. rhamnosus* (20 mg as lyophilized), 2 × 10^9^ CFU*B. animalis* subsp.*lactis* (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, and 5 mg talc."
